Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001–2017

What is it about?

Interstitial lung diseases are rare but are associated with significant morbidity and mortality. The management of ILDs is challenging and there are limited therapies available to slow their progression which have recently been introduced into practice. Although the incidence and mortality from ILDs has increased over the past two decades, there have been significant reductions in mortality rates since the introduction of new therapeutic agents.

Featured Image